The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Interactions Between the Intestinal Microbiome and Liver Diseases
Open accessAbstract
The human intestine harbors a diverse community of microbes that promote metabolism and digestion in their symbiotic relationship with the host. Disturbance of its homeostasis can result in disease. We review factors that disrupt intestinal homeostasis and contribute to nonalcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, and cirrhosis. Liver disease has long been associated with qualitative and quantitative (overgrowth) dysbiotic changes in the intestinal microbiota. Extrinsic factors, such as the Western diet and alcohol, contribute to these changes. Dysbiosis results in intestinal inflammation, a breakdown of the intestinal barrier, and translocation of microbial products in animal models. However, the contribution of the intestinal microbiome to liver disease goes beyond simple translocation of bacterial products that promote hepatic injury and inflammation. Microbial metabolites produced in a dysbiotic intestinal environment and host factors are equally important in the pathogenesis of liver disease. We review how the combination of liver insult and disruptions in intestinal homeostasis contribute to liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the impact of changes to the composition and function of the microbiome in NASH include altered bile acid metabolism and loss of integrity of the gut-vascular barrier, precipitating leakage of LPS and bacteria into the liver via the portal circulation (14–16).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [14]
In the citing paper
“Changes in gut microbiota (dysbiosis) may play a key role in the pathogenesis of NAFLD/NASH and cholestasis52–54 and may also impact on BA composition and signalling.51 55”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [54]
In the citing paper
“However, a failing gut barrier and alterations of the gut microbiota in chronic liver disease (CLD) contribute to chronic inflammation and the progression of liver diseases12, and thereby increase risk for the development of hepatocellular carcinoma (HCC) as the final stage of the disease process 13–15.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
In the citing paper
“Metagenomic studies have revealed substantial alterations in the composition of the gut microbiota in a range of CLD as well as in patients with cirrhosis12,32.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
Bäckhed, F., Manchester, J. K., Semenkovich, C. F., & Gordon, J. I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605374104 · Cited by 2,615
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 974
Probiotics—A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases
Ramachandran, G., & Pottakkat, B. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2023.k.0129 · Cited by 5
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis
Hofer, B., Simbrunner, B., Königshofer, P., Brusilovskaya, K., Petrenko, O., Țâru, V., Sorz, T., Zinober, K., Semmler, G., Kauschke, S. G., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.09.006 · Cited by 5
Debré, P., & Gall, J. L. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31175-6 · Cited by 6
Darm-Leber-Achse – wie der Darm die Leber krank macht
Demir, M., & Tacke, F. (2022) · Die Innere Medizin · doi:10.1007/s00108-022-01398-6 · Cited by 5
Lin, J., Lü, Z., Li, G., Zhang, C., Lu, H., Gao, S., Zhu, R., Huang, H., Aden, K., Wang, J., et al. (2022) · Journal of Innate Immunity · doi:10.1159/000526784 · Cited by 5
Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics
Banc‐Husu, A. M., Shiau, H. H., Dike, P. N., & Shneider, B. L. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1759613 · Cited by 5
Long, J., Gong, J., Zhu, H., Liu, X., Li, L., Chen, B., Ren, H., Liu, C., Lu, H., Zhang, J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1232180 · Cited by 5
The Interplay Between Gut Microbiota and Central Nervous System
Gervasi, T., & Mandalari, G. (2023) · Current Pharmaceutical Design · doi:10.2174/0113816128264312231101110307 · Cited by 5
Akhlaghi, E., Salari, E., Mansouri, M., Shafiei, M., Kalantar-Neyestanaki, D., Aghassi, H., & Harandi, M. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-70005-5 · Cited by 5
The Role of Probiotics in Managing Metabolic-Associated Fatty Liver Disease: An Updated Review
Białczyk, A., Rajewska, A., Junik, R., & Suwała, S. (2024) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.12.2.2 · Cited by 5
Fecal Bile Acids in Canine Chronic Liver Disease: Results from 46 Dogs
Habermaass, V., Bartoli, F., Gori, E., Dini, R., Cogozzo, A., Puccinelli, C., Pierini, A., & Marchetti, V. (2024) · Animals · doi:10.3390/ani14213051 · Cited by 5
Li, N., Chen, X., Xiong, S., Cheng, Y., Deng, J., Zhang, J., Yu, F., Hao, L., Li, S., & Hu, X. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1362139 · Cited by 5
The evolving role of the microbiome in liver failure and liver transplantation
Watt, K. D. S. (2016) · Liver Transplantation · doi:10.1002/lt.24623 · Cited by 5
CD40 signaling and hepatic steatosis: Unanticipated links
Lepreux, S., Villeneuve, J., Dewitte, A., Bérard, A. M., Desmoulière, A., & Ripoche, J. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.11.002 · Cited by 6
Stephens, C. M., Lucena, M. I., & Andrade, R. J. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_23 · Cited by 5
de Oliveira, R. B., Martinelli, A. L. C., Troncon, L. E. D. A., & Elías, J. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-223531 · Cited by 5
Mikrobiom & NASH – enge Komplizen in der Progression von Fettlebererkrankungen
Wree, A., Geisler, L. J., & Tacke, F. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0755-2595 · Cited by 5
Ge, J., Li, H., Yang, J., Yue, Y., Lu, S., Nie, H., Zhang, T., Sun, P., Yan, H., Sun, H., et al. (2023) · Medicine · doi:10.1097/md.0000000000033698 · Cited by 5
Bacterial translocation in liver cirrhosis: Site and role in fibrogenesis
Matuchansky, C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.015 · Cited by 5
Microplastics induce liver inflammation in cattle through the rumen microbiota-gut-liver axis
Li, Z., Ge, Y., Ma, X., Jiang, S., Liang, Z., Liu, L., Luo, Y., Xia, C., Liu, H., Liu, Q., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02399-5 · Cited by 5
Molecular Insights of Nonalcoholic Fatty Liver Disease Pathogenesis
Dawood, R. M., Salum, G. M., El-Meguid, M. A., & Fotouh, B. E.-S. (2024) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2023.0162 · Cited by 4
Epidemiology and Pathogenesis of Alcoholic Liver Disease
Gao, B., & Zakhari, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00022-7 · Cited by 4
Novel drug discovery strategies for the treatment of decompensated cirrhosis
Lamatsch, S., Sittner, R., Tacke, F., & Engelmann, C. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.2020755 · Cited by 4
Parasitosis by Fasciola hepatica and Variations in Gut Microbiota in School-Aged Children from Peru
Silva-Caso, W. G., Carrillo‐Ng, H., Aguilar-Luis, M. Á., Tarazona-Castro, Y., del Valle, L. J., Tinco-Valdez, C., Palomares-Reyes, C., Urteaga, N., Bazán-Mayra, J. E., & del Valle-Mendoza, J. (2024) · Microorganisms · doi:10.3390/microorganisms12020371 · Cited by 6
Li, Y., Liu, D., He, Y., Zhang, Z., Zeng, A., Fan, C., Lyu, L., He, Z., & Ding, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1443182 · Cited by 4
Orzuna‐Orzuna, J. F., Lara-Bueno, A., Gloria-Trujillo, A., Martínez, G. D. M., Miranda‐Romero, L. A., & Hernández-García, P. A. (2024) · Veterinary Sciences · doi:10.3390/vetsci11110520 · Cited by 5
Hepcidin Exacerbates Iron Metabolism Imbalance in Septic Mice
Wu, L., Yuan, Z., Wang, M., Fu, X., Liu, X., Wei, B., & Liu, Y. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s484103 · Cited by 4
Species differences of fatty liver diseases: comparisons between human and feline
Ling, L., Li, R., Xu, M., Zhou, J., Hu, M., Zhang, X., & Zhang, X.-J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2024 · Cited by 5
Pathogenesis and Evolution of Liver Fibrosis: Cirrhosis or Cirrhoses?
Saffioti, F., & Pinzani, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-13614-1_1 · Cited by 4
Progress in inflammasome activation and pyrolysis in alcoholic liver disease.
Wang, S., & Qing, D. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.190272 · Cited by 4
Rol de la microbiota intestinal en el desarrollo del hígado graso no alcohólico
Tumani, M. F., Tapia, G., Aguirre, C. A., Obregón, A. M., & Pettinelli, P. (2021) · Revista médica de Chile · doi:10.4067/s0034-98872021000400570 · Cited by 5
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system
Meroni, M., Paolini, E., Longo, M., Piciotti, R., Tria, G., Fargion, S. R., Fracanzani, A. L., & Dongiovanni, P. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.19 · Cited by 4
Akkermansia muciniphila – multifunctional bacteria
Wosińska, A., PAZIK, D., Łopuszyńska, I., KOSECKA, K., Rudziński, P., Cieślik, A., Jargieło, A., KOSIERADZKA, K., ADAMOWICZ, D., & Stańczyk, J. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.21.01.009 · Cited by 4
Parola, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.017 · Cited by 4
Barve, A. J., Marsano, L. S., Parajuli, D., Cave, M. C., & McClain, C. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-30103-7_13 · Cited by 4
Qin, X., Wang, S., Yan, Z., Zhao, N., & Yao, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1608137 · Cited by 3
Wu, Y., Le, W., Zhang, H., & Zhu, Y. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123879 · Cited by 4
Mousa, N., Elmetwalli, A., Abdelsalam, M., Wahba, M., Selim, M. A., Nour, D., Abdelkader, E., El-Eraky, A., Hasson, A., Taha, A., et al. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00774-5 · Cited by 3
Marinaccio, C., Giovanetti, M., Neri, B., Biasutto, D., D’Amico, A., Altomare, A., Branda, F., Restaneo, L., Ciccozzi, M., Cicala, M., et al. (2026) · Antibiotics · doi:10.3390/antibiotics15050445 · Cited by 3
Мікробіота та захворювання гепатобіліарної системи: нові можливості в лікуванні дітей раннього віку
Shadrin, O. H., & Чернега, Н. Ф. (2020) · CHILD`S HEALTH · doi:10.22141/2224-0551.5.65.2015.74877 · Cited by 3
Fan, W. H., Tang, K., Deng, Y., Zheng, C., Pan, M., Pi, D., Zheng, L., Zhen, J., Yang, Q., & Zhang, Y. (2024) · Food Bioengineering · doi:10.1002/fbe2.12076 · Cited by 3
Zhang, Q., Liang, Y., Li, J., Li, L. X., Meng, L., Zeng, Q., Wang, D., Wang, R., Tong, T., Liu, Y., et al. (2025) · Biology · doi:10.3390/biology14091164 · Cited by 3
Alcohol and the Brain-Liver Axis: A Further Case of Mind Over Matter?
McKillop, I. H. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12652 · Cited by 3
Human microbiome and environmental disease
Zhang, G., & Heng, H. Q. (2017) · Environmental Disease · doi:10.4103/ed.ed_6_17 · Cited by 3
Vermathen, P., Diserens, G., Kröll, D., Nett, P. C., Stirnimann, G., & Wiest, R. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4432 · Cited by 3
Karim, M., Ahmed, O. H., Hanan, A. A., Hassan, M. H., & sabry, A. M. M. (2021) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2021.110816 · Cited by 3
Gut Homeostasis; Microbial Cross Talks in Health and Disease Management
Khatri, G. S., Kurian, C., Anand, A., & Paari, K. A. (2021) · Current Research in Nutrition and Food Science Journal · doi:10.12944/crnfsj.9.3.28 · Cited by 3
Mohammadi, S., Rostamkhani, F., Malayeri, S. R., & Shirvani, H. (2021) · Sport Sciences for Health · doi:10.1007/s11332-021-00829-5 · Cited by 3
韩, 志. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.125700 · Cited by 3
Beer-gut microbiome alliance: a discussion of beer-mediated immunomodulation via the gut microbiome
Zhang, S., Jin, S., Zhang, C., Hu, S., & Li, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1186927 · Cited by 4
Skladaný, Ľ., Koller, T., Kukla, M., & Šoltýs, K. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-34884-6_9 · Cited by 3
Yan, H., Xu, G., Bei, L., Jiang, S., & Zhang, R. (2023) · Poultry Science · doi:10.1016/j.psj.2023.103265 · Cited by 3
Li, Y., Yang, Y., Zheng, Y., Gao, Y., Shu, G., Gai, W., Guo, Y., & Deng, X. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s452705 · Cited by 3
Yang, Y., Wang, J., Su, Q., Yang, J., Bo, Z., Zheng, C., Xie, Y., Chen, K., Wang, J., Chen, G., et al. (2024) · Nature and Science of Sleep · doi:10.2147/nss.s458491 · Cited by 3
Lin, Y., Tsai, Y., Tsai, M.-J., Huang, P., Chen, C., Yao, C., Chuah, S., Kuo, Y., Tai, W., Lian, W., et al. (2024) · Advances in digestive medicine · doi:10.1002/aid2.13367 · Cited by 3
Huang, X. Q., Ai, Y., Li, F., Ye, S. T., Wang, J. H., Zhang, R., Zhang, W., Zhu, Y. L., & Chen, S. (2024) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13314 · Cited by 4
Zhang, Q., Cui, J., Hou, Y., Guo, L., Li, H., Zhou, G., Wang, X., Zhu, B., Shi, K., Zhang, Y., et al. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70392 · Cited by 5
Игоревна, Л. О., Александровна, Н. Е., & Etkina, E. I. (2018) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj201863366-373 · Cited by 3
Early Exposure to Gut Microbiome Reduces Hepatocellular Carcinoma Risks in Mice
Lee, Y.-M., Chang, W., Lei, F., Kor, C., Lai, H., Chen, Y., & Ma, W. (2020) · BioMed Research International · doi:10.1155/2020/9807379 · Cited by 3
Structural and Morphological Changes in the Liver Due to Intestinal Endotoxins
Малев, А. Л., Zakharova, A. N., Kaliberdenko, V. B., Fominykh, T. A., Kulanthaivel, S., & Balasundaram, K. (2020) · Reviews on Recent Clinical Trials · doi:10.2174/1574887115666200617143422 · Cited by 3
The metabolic role of the microbiota
Barton, W., Shanahan, F., Cotter, P. D., & O’Sullivan, Ó. (2015) · Clinical Liver Disease · doi:10.1002/cld.455 · Cited by 3
Bacterial Infection of Liver: A Bird’s Eye View
Parvez, M. K., & Niyazi, S. (2016) · Journal of Gastroenterology and Hepatology Research · doi:10.17554/j.issn.2224-3992.2016.05.624 · Cited by 3
Sanchez-Torrijos, Y. M., Álvarez‐Amor, L., Aller, R., García‐Luna, P. P., Martín, F., & Romero‐Gómez, M. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_15 · Cited by 4
Crawford, M. S., Mohr, A. E., & Sweazea, K. L. (2020) · Journal of Nutrition and Metabolism · doi:10.1155/2020/8846401 · Cited by 3
A Comprehensive Review of Transaminitis and Irritable Bowel Syndrome
Gadour, E., Hassan, Z., & Gadour, R. (2021) · Cureus · doi:10.7759/cureus.16583 · Cited by 3
Fang, C., Du, H., Xiaojiao, Z., Zhao, A., Jia, W. P., & Xu, Y. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/437731 · Cited by 3
Phenazines Modulate Gastrointestinal Metabolism and MicrobiotaPreprint
Peng, W., Li, H., Zhao, X., Shao, B., & Zhu, K. (2021) · Research Square · doi:10.21203/rs.3.rs-1065985/v1 · Cited by 3
Wu, N., Yim, H. C. H., Grimm, M., & El-Omar, E. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65657-x · Cited by 3
Hepatic Steatosis and Microbiota: A Regional Study on Patients from Western Romania
Mihele, A. I., John, H. T., Negruţ, N., Ferician, A. C., Marian, P., & Manole, F. (2025) · Gastrointestinal Disorders · doi:10.3390/gidisord7010009 · Cited by 2
Effects of Dairy Matrix on the Intestinal, Liver, and Bone Transcriptome of Healthy Rats
Zhao, X., Rasmussen, M. K., Hansen, A. K., & Bertram, H. C. (2025) · Foods · doi:10.3390/foods14081375 · Cited by 2
Vaithiyam, V. S., Sachdeva, S., Aneesh, P. S. R., Reddy, R. T., Chittem, R., Ahuja, A., Mehta, K., Dalal, A., & Kumar, A. (2025) · Cureus · doi:10.7759/cureus.85516 · Cited by 2
Kim, S., Park, S., Ansari, A., Lee, G., Hur, Y. M., An, J., Lee, S., You, Y., & Kim, Y. J. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70153 · Cited by 2
Chen, Y., Bi, Y., Zhou, C., Song, J., Qi, M., Gu, Y., Tan, Y., & Qi, J. (2025) · Biomedical Optics Express · doi:10.1364/boe.571101 · Cited by 2
Liao, Y., Huang, J. C., Lin, B., Liang, J., & Huang, K. (2025) · Gastroenterology Research and Practice · doi:10.1155/grp/5540686 · Cited by 2
Emmanuel, A., Raza, B., Ramzan, M. N., & Zheng, Z. (2025) · Aquaculture International · doi:10.1007/s10499-025-02349-2 · Cited by 2
Aging Triggers an Intestinal Energy Crisis and HDL3 Deficiency Disrupting Gut–Liver Axis Homeostasis
Li, Y., Bao, T., Gao, L., Tian, X., Xue, J., Jin, C., Wang, S., & Wu, X. (2026) · Aging Cell · doi:10.1111/acel.70445 · Cited by 2
Zheng, S., Cheng, F.-E., Li, X., Du, H., Zhang, P., Zao, X., Ye, Y., & Shi, X. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101490 · Cited by 2
Influence of other nutrients (e.g., l-arginine, taurine, and choline) on liver diseases
López‐Cervántes, J., Sánchez‐Machado, D. I., Campas‐Baypoli, O. N., Soto, E. U. C., & de la Mora-López, G. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816488-4.00003-6 · Cited by 2
Nagasaka, M., Al-Share, B. A., Shao, Y. F., Sexton, R. E., Hallak, M. N. A., Azmi, A. S., & Sukari, A. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00047-4 · Cited by 3
Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps
Kugelmas, M., Zapata, I., Tawil, J., Pessetto, A., Taglienti, M., & Kugelmas, M. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07561-1 · Cited by 2
Boichak, M. P., Fedorova, O. O., Illyashenko, Y. M., Zhurko, M. M., & Antonov, A. B. (2022) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs07.03.014 · Cited by 2
Lara, C., López-Bermudo, L., Gómez, M. F., Cornejo, A., Berná, G., & Romero‐Gómez, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00019-7 · Cited by 3
Zhang, M., Yang, J., Wu, T., Zhao, Q., Li, H., Zhang, H., Lu, Y., Chen, S., Liu, T., Gong, Z., et al. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124352 · Cited by 2
Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients
Virseda‐Berdices, A., Martín‐Escolano, R., Berenguer, J., González‐García, J., Brochado‐Kith, O., Rojo, D., Díez, C., Hontañón, V., Latorre, L. P., Ibáñez, L., et al. (2024) · Liver International · doi:10.1111/liv.16204 · Cited by 2
Lead Mediated Lipopolysaccharides Exacerbates Fatty Liver Processes in High‐Fat Diets‐Induced Mice
Nie, P., Hu, L., You, T., Jia, T., & Xu, H. (2024) · Environmental Toxicology · doi:10.1002/tox.24463 · Cited by 2
Dandan, Y., Wuyunsiqin, YanNiu, Hashentuya, Tana, Анна, Ma, M., Zhao, W., Menggenduxi, & Wang, M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1517082 · Cited by 2
Microbiota, Inflammation, and Gut Barrier Dysfunction in HCC
Ram, A. K., Wright, G. A. K., & Vairappan, B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89578 · Cited by 2
(2015) · Inflammation and Cell Signaling · doi:10.14800/ics.643 · Cited by 2
Skivka, L. M. (2015) · Biotechnologia Acta · doi:10.15407/biotech8.03.028 · Cited by 2
Debré, P. (2017) · Biologie Aujourd hui · doi:10.1051/jbio/2017012 · Cited by 2
Meissner, E. G. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy208 · Cited by 2
Microbiome of Hepatobiliary Diseases
Kim, Y., & Choi, D. (2018) · Hanyang Medical Reviews · doi:10.7599/hmr.2018.38.2.80 · Cited by 2
Curcumin protects remote organs against injury that is caused by intestinal ischemia and reperfusion
Borges, S. C., Tironi, L. M. T., da Silva, L. M., & Buttow, N. C. (2020) · Acta Scientiarum Biological Sciences · doi:10.4025/actascibiolsci.v42i1.50588 · Cited by 2
Zhuo, L., Xu, J., You, N., Wang, L., Song, Y., Luo, Y., & Shi, J. (2020) · Medicine · doi:10.1097/md.0000000000022867 · Cited by 2
Salvati, A., Faita, F., Cavallone, D., Ricco, G., Colombatto, P., Coco, B., Romagnoli, V., Oliveri, F., Bonino, F., & Brunetto, M. R. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.115 · Cited by 2
Gut–liver–brain axis in chronic liver disease with a focus on hepatic encephalopathy
de la Vera, A. L., Welsch, C., Pfeilschifter, W., & Trebicka, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00004-8 · Cited by 2
HEPATOPROTECTIVE ACTIVITY OF WATER KEFIR
(2021) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2021/10.6.5493 · Cited by 2
Acute on Chronic Liver Failure: An Update
Gupta, M., & Maiwall, R. (2023) · Springer eBooks · doi:10.1007/978-981-19-6045-1_43 · Cited by 2
Probiotics and hepatoprotectors in the treatment of acute viral hepatitis
Zhdanovich, L. G., & Мартынов, В. А. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-206-10-8-13 · Cited by 2
Vadakkan, K., Rajesh, K. S., Tarachandra, S., C, B. R. K., & Joshi, H. N. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00896 · Cited by 2
Metadata
- Authors
- Schnabl, B., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Schnabl, Bernd
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 146
- Issue
- 6
- Pages
- 1513-1524
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3996054
- OpenAlex
- W1975691929
- Cited by
- 971
- References
- 86
- Citations by year
- 2026: 37 · 2025: 56 · 2024: 88 · 2023: 101 · 2022: 88 · 2021: 92 · 2020: 102 · 2019: 88 · 2018: 89 · 2017: 58 · 2016: 64 · 2015: 77 · 2014: 31
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (U01 AA021856, R01 AA020703, 2 P42 ES010337, K08 DK081830)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- gut microbiota, gut-liver axis, non-alcoholic fatty liver disease, steatohepatitis, alcoholic liver disease, liver cirrhosis, dysbiosis, intestinal homeostasis, intestinal barrier dysfunction, intestinal inflammation, microbial translocation, microbial metabolites, Western diet, alcohol
- MeSH terms
- Animals, Bacteria, Bile Acids and Salts, Fatty Liver, Humans, Intestines, Liver Cirrhosis, Liver Diseases, Liver Diseases, Alcoholic, Risk Factors, Host-Pathogen Interactions, Microbiota, Dysbiosis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
